Skip to main content
72°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
ELV
)
534.32
-0.97 (-0.18%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ELV
< Previous
1
2
3
4
5
6
7
Next >
Deep Dive Into Elevance Health Stock: Analyst Perspectives (7 Ratings)
April 04, 2024
Via
Benzinga
Israel Kills Top Iranian General – Oil Rises – Not Great For Stock Market's No Inflation Story
April 02, 2024
To gain an edge, this is what you need to know today. Raise Hedges It is time to raise hedges. As full disclosure, a signal was given to The Arora Report members.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
UnitedHealth, Health Insurers Tumble On Medicare Advantage Rates
April 01, 2024
Final Medicare Advantage rates were unchanged vs. the initial proposal.
Via
Investor's Business Daily
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
April 01, 2024
Via
Benzinga
How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows
March 28, 2024
Study reveals stark contrast: Novo Nordisk's Ozempic diabetes drug costs nearly $1,000 monthly in the U.S., yet could be produced for less than $5. This underscores the affordability challenge faced by...
Via
Benzinga
How Is The Market Feeling About Elevance Health?
March 26, 2024
Via
Benzinga
$100 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today
March 13, 2024
Via
Benzinga
Analyst Scoreboard: 6 Ratings For Elevance Health
March 06, 2024
Via
Benzinga
Insurance Coverage For Weight Loss Drugs - Elevance, CVS Health Become First To Extend Coverage To Novo Nordisk's Successful Wegovy For Certain Patients
March 28, 2024
Major U.S. health insurers CVS Health, Elevance Health, and Kaiser Permanente now reimburse for Novo Nordisk's Wegovy for specific Medicare individuals with heart-related conditions. This shift aims to...
Via
Benzinga
3 Stocks To Buy For Decreased Volatility
March 23, 2024
Here are three low-beta stocks that could all be considered for those looking for a more conservative approach.
Via
Talk Markets
3 Stocks To Buy For Decreased Volatility
March 20, 2024
Beta measures a stock's volatility in comparison to a relevant benchmark. The market, such as the S&P 500 Index, has a beta of 1.0.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Kroger Passes The Baton: Sells Specialty Pharmacy Division To CarelonRx
March 19, 2024
Kroger sells specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, for undisclosed amount. Deal expected to close in 2nd half of 2024, will not impact 2024 guidance.
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,500 Today
February 29, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Elevance Health Through Analyst Insights
February 14, 2024
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,200 Today
February 13, 2024
Via
Benzinga
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today
February 01, 2024
Via
Benzinga
Navigating 4 Analyst Ratings For Elevance Health
January 25, 2024
Via
Benzinga
Healthcare Needs Will Soar As The Population Grows Older, Presenting A Profit Opportunity
February 22, 2024
The aging of our society puts new demands on our economy. A smaller number of working-age people will be expected to support a larger group of older folks who have left the labor force.
Via
Talk Markets
Topics
Economy
Exposures
Economy
Elevance Health (ELV) Q4 2023 Earnings Call Transcript
January 24, 2024
ELV earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Health Insurer Elevance's Q4 Earnings: Dividend Increase, Drop In Medicaid Enrollment, Upbeat 2024 Outlook
January 24, 2024
Elevance Health excels with Q4 2023 revenues of $42.45B, up 7% YoY, surpassing consensus. Explore the growth drivers, profit insights, and future projections.
Via
Benzinga
Humana Stock Falls Ill On This Warning; UNH, CVS Catch Virus
January 18, 2024
Humana slashed its Q4 earnings outlook on higher medical costs and warned about weak Medicare Advantage enrollment.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 12, 2024
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $12,000 Today
January 08, 2024
Via
Benzinga
(ELV) - Analyzing Elevance Health's Short Interest
January 03, 2024
Via
Benzinga
Earnings Scheduled For January 24, 2024
January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion.
Via
Benzinga
Preview: Elevance Health's Earnings
January 23, 2024
Via
Benzinga
Looking Into Elevance Health's Recent Short Interest
January 23, 2024
Via
Benzinga
S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?
January 22, 2024
US stocks rise to record highs on strong earnings reports, with small caps outperforming. Dollar steady, gold down, oil up. Bitcoin tumbles. AMD, TSLA, ADM, GILD, WDC top movers. GE, AAPL, FB, AMZN,...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cigna's Medicare Business Sale: Health Care Service Could Scoop The Business
January 03, 2024
Cigna Group (NYSE: CI) is reportedly in advanced negotiations to divest its Medicare Advantage division and is presently in discussions to sell it to Health Care Service Corp Inc (NASDAQ: HCSG) for...
Via
Benzinga
'AI Is The Story Of The Show': What To Expect From CES 2024
January 03, 2024
Artificial intelligence will take center stage at the massive CES 2024 technology trade show, which opens Tuesday in Las Vegas.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.